Vincent De Smet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vincent De Smet has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Leo Adrianus van Grunsven
Liver Cell Biology Research Group, Vrije Universiteit Brussel, Brussels, Belgium
4 shared publications - Hendrik Reynaert
Department of Hepatogastroenterology, Universitair Ziekenhuis Brussel, Brussels, Belgium
3 shared publications - Nouredin Messaoudi
Department of Hepatopancreatobiliary Surgery, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel and Europe Hospitals, 1090 Brussels, Belgium
3 shared publications - Stefaan Verhulst
Liver Cell Biology Research Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium
3 shared publications Ayla Smout
Vrije Universiteit Brussel, Laarbeeklaan 103, Brussel, 1090, BELGIUM
2 shared publications- Elif Gürbüz
Vrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium
2 shared publications
Latest Publications
- Open Access
- 20 September 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (1) , 101223
Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
- 20 September 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (1) , 101223
Open AccessHepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
- Open Access
- 28 June 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (3) , 035032
Human iPSC-derived liver co-culture spheroids to model liver fibrosis
The lack of adequate human in vitro models that recapitulate the cellular composition and response of the human liver to injury hampers the development of anti-fibrotic drugs. The goal of this study was to develop a human spheroid culture model to study liver fibrosis by using induced pluripotent stem cell (iPSC)-derived liver cells. iPSCs were independently differentiated towards hepatoblasts (iHepatoblasts), hepatic stellate cells (iHSCs), endothelial cells (iECs) and macrophages (iMΦ), before assembly into free floating spheroids by culturing cells in 96-well U-bottom plates and orbital shaking for up to 21 days to allow further maturation. Through transcriptome analysis, we show further maturation of iECs and iMΦ, the differentiation of the iHepatoblasts towards hepatocyte-like cells (iHeps) and the inactivation of the iHSCs by the end of the 3D culture. Moreover, these cultures display a similar expression of cell-specific marker genes (CYP3A4, PDGFRβ, CD31 and CD68) and sensitivity to hepatotoxicity as spheroids made using freshly isolated primary human liver cells. Furthermore, we show the functionality of the iHeps and the iHSCs by mimicking liver fibrosis through iHep-induced iHSC activation, using acetaminophen. In conclusion, we have established a reproducible human iPSC-derived liver culture model that can be used to mimic fibrosis in vitro as a replacement of primary human liver derived 3D models. The model can be used to investigate pathways involved in fibrosis development and to identify new targets for chronic liver disease therapy.
- 28 June 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (3) , 035032
Open AccessHuman iPSC-derived liver co-culture spheroids to model liver fibrosis
The lack of adequate human in vitro models that recapitulate the cellular composition and response of the human liver to injury hampers the development of anti-fibrotic drugs. The goal of this study was to develop a human spheroid culture model to study liver fibrosis by using induced pluripotent stem cell (iPSC)-derived liver cells. iPSCs were independently differentiated towards hepatoblasts (iHepatoblasts), hepatic stellate cells (iHSCs), endothelial cells (iECs) and macrophages (iMΦ), before assembly into free floating spheroids by culturing cells in 96-well U-bottom plates and orbital shaking for up to 21 days to allow further maturation. Through transcriptome analysis, we show further maturation of iECs and iMΦ, the differentiation of the iHepatoblasts towards hepatocyte-like cells (iHeps) and the inactivation of the iHSCs by the end of the 3D culture. Moreover, these cultures display a similar expression of cell-specific marker genes (CYP3A4, PDGFRβ, CD31 and CD68) and sensitivity to hepatotoxicity as spheroids made using freshly isolated primary human liver cells. Furthermore, we show the functionality of the iHeps and the iHSCs by mimicking liver fibrosis through iHep-induced iHSC activation, using acetaminophen. In conclusion, we have established a reproducible human iPSC-derived liver culture model that can be used to mimic fibrosis in vitro as a replacement of primary human liver derived 3D models. The model can be used to investigate pathways involved in fibrosis development and to identify new targets for chronic liver disease therapy.
- Open Access
- 8 February 2024
- Published by Elsevier in JHEP Reports
- Vol. 6 (5) , 101036
Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease
- 8 February 2024
- Published by Elsevier in JHEP Reports
- Vol. 6 (5) , 101036
Open AccessOrphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease
- 1 October 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 73 (4) , 993-995
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2
- 1 October 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 73 (4) , 993-995
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2